Matches in SemOpenAlex for { <https://semopenalex.org/work/W3193457054> ?p ?o ?g. }
- W3193457054 endingPage "279" @default.
- W3193457054 startingPage "269" @default.
- W3193457054 abstract "Cisplatin-based chemotherapy remains the standard care for non-small cell lung cancer (NSCLC) patients. Relapse after chemotherapy-induced dormancy affects the overall survival of patients. The evolution of cancer cells under chemotherapy stress is regulated by transcription factors (TFs) with binding sites initially buried deep within inaccessible chromatin. The transcription machinery and dynamic epigenetic alterations during the process of dormancy-reactivation of lung cancer cells after chemotherapy need to be investigated. Here, we investigated the chromatin accessibility of lung cancer cells after cisplatin treatment, using an assay for transposase-accessible chromatin sequencing (ATAC-seq). We observed that global chromatin accessibility was extensively improved. Transcriptional Regulatory Relationships Unraveled by Sentence-based Text mining (TRRUST) v.2 was used to elucidate TF-target interaction during the process of dormancy and reactivation. Enhancer regions and motifs specific to key TFs including JUN, MYC, SMAD3, E2F1, SP1, CTCF, SMAD4, STAT3, NFKB1, and KLF4 were enriched in differential loci ATAC-seq peaks of dormant and reactivated cancer cells induced by chemotherapy. The findings suggest that these key TFs regulated gene expressions during the process of dormancy and reactivation of cancer cells through altering promoter accessibility of target genes. Our study helps advance understanding of how cancer cells adapt to the stress induced by chemotherapy through TF binding motif accessibility. Cisplatin-based chemotherapy remains the standard care for non-small cell lung cancer (NSCLC) patients. Relapse after chemotherapy-induced dormancy affects the overall survival of patients. The evolution of cancer cells under chemotherapy stress is regulated by transcription factors (TFs) with binding sites initially buried deep within inaccessible chromatin. The transcription machinery and dynamic epigenetic alterations during the process of dormancy-reactivation of lung cancer cells after chemotherapy need to be investigated. Here, we investigated the chromatin accessibility of lung cancer cells after cisplatin treatment, using an assay for transposase-accessible chromatin sequencing (ATAC-seq). We observed that global chromatin accessibility was extensively improved. Transcriptional Regulatory Relationships Unraveled by Sentence-based Text mining (TRRUST) v.2 was used to elucidate TF-target interaction during the process of dormancy and reactivation. Enhancer regions and motifs specific to key TFs including JUN, MYC, SMAD3, E2F1, SP1, CTCF, SMAD4, STAT3, NFKB1, and KLF4 were enriched in differential loci ATAC-seq peaks of dormant and reactivated cancer cells induced by chemotherapy. The findings suggest that these key TFs regulated gene expressions during the process of dormancy and reactivation of cancer cells through altering promoter accessibility of target genes. Our study helps advance understanding of how cancer cells adapt to the stress induced by chemotherapy through TF binding motif accessibility." @default.
- W3193457054 created "2021-08-30" @default.
- W3193457054 creator A5002287414 @default.
- W3193457054 creator A5007646350 @default.
- W3193457054 creator A5012764458 @default.
- W3193457054 creator A5035017157 @default.
- W3193457054 creator A5040206102 @default.
- W3193457054 creator A5045635579 @default.
- W3193457054 creator A5048586786 @default.
- W3193457054 creator A5062223803 @default.
- W3193457054 creator A5064417499 @default.
- W3193457054 date "2021-12-01" @default.
- W3193457054 modified "2023-10-12" @default.
- W3193457054 title "Chromatin accessibility regulates chemotherapy-induced dormancy and reactivation" @default.
- W3193457054 cites W1945773609 @default.
- W3193457054 cites W1964963969 @default.
- W3193457054 cites W1969652605 @default.
- W3193457054 cites W1986980014 @default.
- W3193457054 cites W2000285730 @default.
- W3193457054 cites W2011084862 @default.
- W3193457054 cites W2016194516 @default.
- W3193457054 cites W2028852886 @default.
- W3193457054 cites W2088035579 @default.
- W3193457054 cites W2096083625 @default.
- W3193457054 cites W2101142880 @default.
- W3193457054 cites W2135215848 @default.
- W3193457054 cites W2172286207 @default.
- W3193457054 cites W2465336312 @default.
- W3193457054 cites W2532063601 @default.
- W3193457054 cites W2782454362 @default.
- W3193457054 cites W2789855762 @default.
- W3193457054 cites W2795897259 @default.
- W3193457054 cites W2897235350 @default.
- W3193457054 cites W2906616100 @default.
- W3193457054 cites W2907794898 @default.
- W3193457054 cites W2916494903 @default.
- W3193457054 cites W2952507499 @default.
- W3193457054 cites W2969669884 @default.
- W3193457054 cites W2972571020 @default.
- W3193457054 cites W2996769621 @default.
- W3193457054 cites W3005037272 @default.
- W3193457054 cites W3005203352 @default.
- W3193457054 cites W4211018930 @default.
- W3193457054 doi "https://doi.org/10.1016/j.omtn.2021.07.019" @default.
- W3193457054 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8413835" @default.
- W3193457054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34513309" @default.
- W3193457054 hasPublicationYear "2021" @default.
- W3193457054 type Work @default.
- W3193457054 sameAs 3193457054 @default.
- W3193457054 citedByCount "9" @default.
- W3193457054 countsByYear W31934570542021 @default.
- W3193457054 countsByYear W31934570542022 @default.
- W3193457054 countsByYear W31934570542023 @default.
- W3193457054 crossrefType "journal-article" @default.
- W3193457054 hasAuthorship W3193457054A5002287414 @default.
- W3193457054 hasAuthorship W3193457054A5007646350 @default.
- W3193457054 hasAuthorship W3193457054A5012764458 @default.
- W3193457054 hasAuthorship W3193457054A5035017157 @default.
- W3193457054 hasAuthorship W3193457054A5040206102 @default.
- W3193457054 hasAuthorship W3193457054A5045635579 @default.
- W3193457054 hasAuthorship W3193457054A5048586786 @default.
- W3193457054 hasAuthorship W3193457054A5062223803 @default.
- W3193457054 hasAuthorship W3193457054A5064417499 @default.
- W3193457054 hasBestOaLocation W31934570541 @default.
- W3193457054 hasConcept C100701293 @default.
- W3193457054 hasConcept C104317684 @default.
- W3193457054 hasConcept C111936080 @default.
- W3193457054 hasConcept C143998085 @default.
- W3193457054 hasConcept C2776256026 @default.
- W3193457054 hasConcept C2776694085 @default.
- W3193457054 hasConcept C2778239845 @default.
- W3193457054 hasConcept C3527866 @default.
- W3193457054 hasConcept C502942594 @default.
- W3193457054 hasConcept C54355233 @default.
- W3193457054 hasConcept C59822182 @default.
- W3193457054 hasConcept C71924100 @default.
- W3193457054 hasConcept C83640560 @default.
- W3193457054 hasConcept C86339819 @default.
- W3193457054 hasConcept C86803240 @default.
- W3193457054 hasConcept C95444343 @default.
- W3193457054 hasConceptScore W3193457054C100701293 @default.
- W3193457054 hasConceptScore W3193457054C104317684 @default.
- W3193457054 hasConceptScore W3193457054C111936080 @default.
- W3193457054 hasConceptScore W3193457054C143998085 @default.
- W3193457054 hasConceptScore W3193457054C2776256026 @default.
- W3193457054 hasConceptScore W3193457054C2776694085 @default.
- W3193457054 hasConceptScore W3193457054C2778239845 @default.
- W3193457054 hasConceptScore W3193457054C3527866 @default.
- W3193457054 hasConceptScore W3193457054C502942594 @default.
- W3193457054 hasConceptScore W3193457054C54355233 @default.
- W3193457054 hasConceptScore W3193457054C59822182 @default.
- W3193457054 hasConceptScore W3193457054C71924100 @default.
- W3193457054 hasConceptScore W3193457054C83640560 @default.
- W3193457054 hasConceptScore W3193457054C86339819 @default.
- W3193457054 hasConceptScore W3193457054C86803240 @default.
- W3193457054 hasConceptScore W3193457054C95444343 @default.
- W3193457054 hasFunder F4320321001 @default.
- W3193457054 hasFunder F4320321514 @default.